Progesterone influence on neurite outgrowth involves microglia.
Progesterone (P4) antagonizes estradiol (E2) in synaptic remodeling in the hippocampus during the rat estrous cycle. To further understand how P4 modulates synaptic plasticity, we used entorhinal cortex lesions, which induce E2-dependent neurite sprouting in the hippocampus. In young ovariectomized rats, the E2-dependent entorhinal cortex lesion-induced sprouting was attenuated by concurrent treatment with P4 and E2. Microglial activation also showed the E2-P4 antagonism. These findings extend reports on the estrous cycle synaptic remodeling without lesions by showing the P4-E2 antagonism during simultaneous treatment with both E2 and P4. Glial mechanisms were analyzed with the wounding-in-a-dish model of cocultured glia and embryonic d-18 cortical neurons from rat. In cocultures of mixed glia (astrocytes plus 30% microglia), P4 antagonized the E2-dependent neurite outgrowth (number and length) and neuron viability in the presence of E2, as observed in vivo. However, removal of microglia (astrocyte-neuron coculture) abolished the antagonism of E2 by P4 on neuron sprouting. The P4 receptor antagonists ORG-31710 and RU-486 blocked the antagonism of P4 on E2-dependent sprouting. These findings suggest a new role for microglia in P4 antagonism of E2 in neuronal plasticity and show its dependence on progesterone receptors. These findings are also relevant to the inclusion of progestins in hormone therapy, which is controversial in relation to cognitive declines during aging and in Alzheimer's disease.
Wong
Angela M
AM
Biogerontology Division, Davis School of Gerontology, University of Southern California, Los Angeles, California 90089, USA.
Rozovsky
Irina
I
Arimoto
Jason M
JM
Du
Yizhou
Y
Wei
Min
M
Morgan
Todd E
TE
Finch
Caleb E
CE
D000818:Animals; D000831:Animals, Newborn; D018929:Cell Culture Techniques; D004958:Estradiol / Q000494:pharmacology*; D004965:Estrogen Antagonists / Q000494:pharmacology; D005260:Female; D017628:Microglia / Q000166:cytology / Q000187:drug effects / Q000502:physiology*; D016501:Neurites / Q000187:drug effects / Q000502:physiology*; D009474:Neurons / Q000187:drug effects / Q000502:physiology; D010052:Ovariectomy; D011374:Progesterone / Q000494:pharmacology*; D051381:Rats; D013569:Synapses / Q000187:drug effects / Q000502:physiology
D004965:Estrogen Antagonists; D011374:Progesterone; D004958:Estradiol
Brain Res. 2006 Jul 12;1099(1):206-10
16793026
Science. 1985 Dec 6;230(4730):1179-81
4071042
J Endocrinol Invest. 2000 Mar;23(3):151-7
10803471
Brain Res. 2004 Jul 23;1015(1-2):169-74
15223381
Endocrinology. 1998 Jul;139(7):3202-9
9645694
J Neurosci. 2002 May 15;22(10):4095-102
12019328
Exp Neurol. 2000 Sep;165(1):46-57
10964484
Neuroscience. 1999;91(3):1009-16
10391478
Hippocampus. 1997;7(3):341-9
9228530
Exp Cell Res. 2005 Oct 1;309(2):305-15
16038898
J Peripher Nerv Syst. 2006 Jun;11(2):111-8
16787508
Eur J Neurosci. 1999 Sep;11(9):3359-64
10510203
Exp Neurol. 1992 Oct;118(1):47-52
1397175
J Biol Chem. 1994 Apr 22;269(16):11945-9
8163495
J Neurosci. 1999 Nov 15;19(22):RC42
10559432
Brain Res. 2005 Jul 5;1049(1):112-9
15932748
J Comp Neurol. 2007 Sep 1;504(1):42-56
17614295
Hum Reprod. 1994 Jun;9 Suppl 1:77-81
7962474
Ann Emerg Med. 2007 Apr;49(4):391-402, 402.e1-2
17011666
Endocrinology. 2006 Nov;147(11):5303-13
16916950
Endocr Rev. 2007 Jun;28(4):387-439
17431228
Science. 1984 Sep 21;225(4668):1287-94
6382610
Brain Res. 1980 May 19;190(1):195-214
6769533
Menopause. 2007 May-Jun;14(3 Pt 2):572-9
17476147
JAMA. 2004 Jun 23;291(24):2947-58
15213206
J Comp Neurol. 1979 Feb 1;183(3):539-49
759447
FASEB J. 2003 Jun;17(9):1110-1
12692086
Hum Reprod. 1994 Jun;9 Suppl 1:47-52
7962469
Neurobiol Aging. 1998 Jan-Feb;19(1):97-103
9562510
J Cell Biol. 1980 Jun;85(3):890-902
6248568
Neurobiol Aging. 2005 May;26(5):705-15
15708446
JAMA. 2003 May 28;289(20):2651-62
12771112
Front Neuroendocrinol. 2008 May;29(2):313-39
18374402
J Clin Endocrinol Metab. 2006 May;91(5):1802-10
16522699
J Neurosci. 1997 Jun 1;17(11):4121-8
9151729
Br J Clin Pharmacol. 1992 Mar;33(3):293-8
1576050
Proc Natl Acad Sci U S A. 1996 Dec 24;93(26):15512-7
8986843
J Neurochem. 2006 Nov;99(4):1263-72
16981890
Neurobiol Aging. 2005 Nov-Dec;26(10):1365-74
16243607
Neurosci Lett. 2008 May 30;437(2):116-20
18439758
Brain Res Brain Res Rev. 2005 Apr;48(2):273-86
15850667
Glia. 2008 Apr 15;56(6):659-74
18286612
Exp Gerontol. 1994 May-Aug;29(3-4):431-6
7925761
J Comp Neurol. 1993 Oct 8;336(2):293-306
8245220
J Neurosci Res. 2004 Jan 15;75(2):203-17
14705141
Proc Natl Acad Sci U S A. 2006 Jun 27;103(26):10041-5
16785436
Endocrinology. 2002 Feb;143(2):636-46
11796520
Neurosci Lett. 2006 May 8;398(3):337-42
16472911
Brain Dev. 1998 Mar;20(2):88-94
9545178
Glia. 2008 Feb;56(3):259-70
18069670
Exp Neurol. 1997 Feb;143(2):313-8
9056393
Trends Neurosci. 1994 Apr;17(4):138-42
7517589
Restor Neurol Neurosci. 2000;16(2):87-96
12671211
Curr Med Chem. 2007;14(27):2865-71
18045132
JAMA. 2004 Jun 23;291(24):2959-68
15213207
Front Biosci. 2008 Jan 01;13:1083-9
17981614
J Anat. 1942 Oct;77(Pt 1):63-96.10
17104917
Am J Physiol Renal Physiol. 2006 Feb;290(2):F306-12
16189295
J Neurosci. 2002 May 1;22(9):3484-92
11978825
Neuroscience. 2005;133(2):423-36
15878805
J Appl Physiol (1985). 2001 Dec;91(6):2785-801
11717247
J Neurosci. 2007 Nov 28;27(48):13357-65
18045930
Endocrinology. 2003 Nov;144(11):4734-8
12960039
JAMA. 2003 May 28;289(20):2663-72
12771113
Front Neuroendocrinol. 2008 Jan;29(1):88-113
17980408
Neuroreport. 2002 May 7;13(6):825-30
11997695
J Neurosci. 2007 Oct 17;27(42):11416-23
17942736
Brain Res. 2004 May 15;1008(1):29-39
15081379